Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Transplant Hepatology Fellowship, Medicine, Duke University School of Medicine 2015 - 2016
  • DCRI Research Fellowship, Duke University School of Medicine 2013 - 2016
  • Gastroenterology Fellowship, Medicine, Duke University School of Medicine 2012 - 2015
  • Internal Medicine Residency, Medicine, Duke University School of Medicine 2008 - 2011
  • M.D., Duke University School of Medicine 2008
  • Ph.D., Duke University 2007
• 

  Previous Appointments & Affiliations

  • Assistant Professor of Medicine, Medicine, Gastroenterology, Medicine 2018 - 2020
  • Lecturer of Sociology, Sociology, Trinity College of Arts & Sciences 2017 - 2018
  • Medical Instructor in the Department of Medicine, Medicine, Gastroenterology, Medicine 2016 - 2018
  • MedicalInstructor in the Department of Medicine, Medicine, General Internal Medicine, Medicine 2011 - 2012
  • Instructor Temporary in the Department of Medicine, Medicine, General Internal Medicine, Medicine 2011
• Recognition
• 

  Awards & Honors

  • Transplant Hepatology Fellowship. DUke Department of Medicine. July 2015
  • Duke Clinical Research Institute Fellowship. Duke Clinical Research Institute. July 2013
  • Gastroenterology T32 Research Fellowship. Duke Department of Medicine. July 2012
  • Duke Center for Demographics. National Institute of Aging Fellowship Award. June 2005
  • Minority Fellowship Program. American Sociological Association and NIMH. June 2004
  • Medical Science Teaching Program Fellowship. DUke School of Medicine. August 2000
  • MARCU*STAR Scholarship Recipient. University of Maryland. June 1999
  • Golden Key Honor Society inductee . University of Maryland Baltimore County. May 1999
• Research
• 

  Selected Grants

  • Duke Training Grant in Digestive Diseases and Nutrition awarded by National Institutes of Health 1988 - 2027
  • Prediction and Prevention of Hepatic Decompensation in Patients with Cirrhosis awarded by National Institutes of Health 2021 - 2026
  • A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients with Primary Sclerosing Cholangitis (VISTAS) awarded by Mirum Pharmaceuticals, Inc. 2021 - 2024
  • Alphapump system in the treatment of refractory or recurrent ascites: a muticenter single arm within subject crossover design pivotal study (The POSEIDON Study) awarded by Sequana Medical NV 2020 - 2023
  • VTEU 13-0053 FY 2020 Option 1-Protocol Implementation awarded by National Institutes of Health 2014 - 2023
  • A Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen with out Interferon for Chronic Hepatitis C Infection in Gilead Sponsored Trials. awarded by Gilead Sciences, Inc. 2015 - 2022
  • The Impact of Race, Ethnicity, and Socioeconomic Status on Listing for Liver Transplant after Referral awarded by American Association for the Study of Liver Diseases 2018 - 2020
  • Gilead HCV Heart and Lung - A Multicenter, open-label study of Harvoni® (sofosbuvir-ledipasvir fixed dose combination) in subjects infected with chronic hepatitis C and advanced heart failure or lung disease awarded by Gilead Sciences, Inc. 2016 - 2020
• 

  External Relationships

  • Health monitor
  • TruLab
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Louissaint, Jeremy, Julius M. Wilder, Elliot B. Tapper, Jorge A. Rodriguez, Russell Rosenblatt, and Elizabeth C. Verna. “Confronting Disparities in Telehepatology Research.” Clin Gastroenterol Hepatol 21, no. 6 (June 2023): 1385–89. https://doi.org/10.1016/j.cgh.2022.11.042.
       Full Text  Link to Item
    • Henson, Jacqueline B., Norine W. Chan, Julius M. Wilder, Andrew J. Muir, and Lisa M. McElroy. “Characterization of social determinants of health of a liver transplant referral population.” Liver Transpl, March 20, 2023. https://doi.org/10.1097/LVT.0000000000000127.
       Full Text  Link to Item
    • Henson, Jacqueline B., Kara Wegermann, Yuval A. Patel, Julius M. Wilder, and Andrew J. Muir. “Access to technology to support telehealth in areas without specialty care for liver disease.” Hepatology 77, no. 1 (January 1, 2023): 176–85. https://doi.org/10.1002/hep.32597.
       Full Text  Link to Item
    • Woodrell, C. D., A. A. Patel, J. M. Wilder, V. Sundaram, R. T. Chung, and N. N. Ufere. “Cultural humility and end-of-life communication with people with advanced liver disease.” Clinical Liver Disease 20, no. 3 (September 1, 2022): 81–85. https://doi.org/10.1002/cld.1225.
       Full Text
    • Park, Christine, Mandisa-Maia Jones, Samantha Kaplan, Felicitas L. Koller, Julius M. Wilder, L Ebony Boulware, and Lisa M. McElroy. “A scoping review of inequities in access to organ transplant in the United States.” Int J Equity Health 21, no. 1 (February 12, 2022): 22. https://doi.org/10.1186/s12939-021-01616-x.
       Full Text  Link to Item
    • Helzberg, James H., Alice Parish, Donna Niedzwiecki, Charles Y. Kim, Yuval A. Patel, Julius M. Wilder, and Andrew J. Muir. “Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes.” Bmj Open Gastroenterol 9, no. 1 (January 2022). https://doi.org/10.1136/bmjgast-2021-000747.
       Full Text  Link to Item
    • Vidal, Adriana C., Cynthia A. Moylan, Julius Wilder, Delores J. Grant, Susan K. Murphy, and Cathrine Hoyo. “Racial disparities in liver cancer: Evidence for a role of environmental contaminants and the epigenome.” Front Oncol 12 (2022): 959852. https://doi.org/10.3389/fonc.2022.959852.
       Full Text  Link to Item
    • Wegermann, Kara, Julius M. Wilder, Alice Parish, Donna Niedzwiecki, Ziad F. Gellad, Andrew J. Muir, and Yuval A. Patel. “Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19.” Dig Dis Sci 67, no. 1 (January 2022): 93–99. https://doi.org/10.1007/s10620-021-06842-5.
       Full Text  Link to Item
    • Rosenblatt, Russell, Hannah Lee, AnnMarie Liapakis, Keri E. Lunsford, Andrew Scott, Pratima Sharma, and Julius Wilder. “Equitable Access to Liver Transplant: Bridging the Gaps in the Social Determinants of Health.” Hepatology 74, no. 5 (November 2021): 2808–12. https://doi.org/10.1002/hep.31986.
       Full Text  Link to Item
    • Ala, Aftab, Julius Wilder, Naudia L. Jonassaint, Carla S. Coffin, Carla Brady, Andrew Reynolds, and Michael L. Schilsky. “COVID-19 and the Uncovering of Health Care Disparities in the United States, United Kingdom and Canada: Call to Action.” Hepatol Commun 5, no. 10 (October 2021): 1791–1800. https://doi.org/10.1002/hep4.1790.
       Full Text  Link to Item
    • Wegermann, Kara, Yuval Patel, and Julius Wilder. “Health Equity and Telemedicine in Gastroenterology and Hepatology.” Clin Gastroenterol Hepatol 19, no. 8 (August 2021): 1516–19. https://doi.org/10.1016/j.cgh.2021.04.024.
       Full Text  Link to Item
    • Helzberg, James H., Rui Dai, Andrew J. Muir, Julius Wilder, Tzu-Hao Lee, Jonathan G. Martin, Charles Y. Kim, and James Ronald. “Socioeconomic Status Is Associated with the Risk of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.” J Vasc Interv Radiol 32, no. 7 (July 2021): 950-960.e1. https://doi.org/10.1016/j.jvir.2020.11.022.
       Full Text  Link to Item
    • Wilder, Julius M., Donna M. Evon, Rae Jean Proeschold-Bell, Jia Yao, Malik Muhammed Sohail, Donna Niedzwiecki, Christina Makarushka, Terra Hodge, and Andrew J. Muir. “Why do patients with chronic hepatitis C drink alcohol? An examination of pain, depression and drinking motives.” J Viral Hepat 28, no. 5 (May 2021): 699–709. https://doi.org/10.1111/jvh.13474.
       Full Text  Link to Item
    • Wilder, Julius M. “The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States.” Clin Infect Dis 72, no. 4 (February 16, 2021): 707–9. https://doi.org/10.1093/cid/ciaa959.
       Full Text  Link to Item
    • Kardashian, Ani, Julius Wilder, Norah A. Terrault, and Jennifer C. Price. “Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to Action.” Hepatology 73, no. 2 (February 2021): 811–20. https://doi.org/10.1002/hep.31605.
       Full Text  Link to Item
    • Proeschold-Bell, Rae Jean, Donna M. Evon, Jia Yao, Donna Niedzwiecki, Christina Makarushka, Kelly A. Keefe, Ashwin A. Patkar, et al. “A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection.” Hepatology 71, no. 6 (June 2020): 1894–1909. https://doi.org/10.1002/hep.31058.
       Full Text  Link to Item
    • Henson, Jacqueline B., Julius M. Wilder, Matthew R. Kappus, Andrew S. Barbas, Cynthia A. Moylan, Donna Niedzwiecki, Andrew J. Muir, Carl L. Berg, and Yuval A. Patel. “Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C.” Transplantation 104, no. 6 (June 2020): e164–73. https://doi.org/10.1097/TP.0000000000003219.
       Full Text  Link to Item
    • “Unclear Statement.” Jama 322, no. 4 (July 23, 2019): 369. https://doi.org/10.1001/jama.2019.9668.
       Full Text  Link to Item
    • Ward, Rachael A., Teminioluwa Ajayi, Tanya Aylward, Jennifer Byrns, Bryant B. Summers, and Julius Wilder. “Multi-disciplinary approach to perioperative risk assessment and post-transplant management for liver transplantation in a patient at risk for Brugada syndrome.” J Perioper Pract 29, no. 5 (May 2019): 140–46. https://doi.org/10.1177/1750458918796013.
       Full Text  Link to Item
    • Wilder, Julius, Steve S. Choi, and Cynthia A. Moylan. “Evaluation for Fibrosis After Cure of Hepatitis C-Reply.” Jama 321, no. 15 (April 16, 2019): 1535. https://doi.org/10.1001/jama.2019.0873.
       Full Text  Link to Item
    • Spiritos, Zachary, Shakirat Salvador, Diana Mosquera, and Julius Wilder. “Acute Intermittent Porphyria: Current Perspectives And Case Presentation.” Ther Clin Risk Manag 15 (2019): 1443–51. https://doi.org/10.2147/TCRM.S180161.
       Full Text  Open Access Copy  Link to Item
    • Wilder, Julius, Steve S. Choi, and Cynthia A. Moylan. “Vibration-Controlled Transient Elastography for Diagnosing Cirrhosis and Staging Hepatic Fibrosis.” Jama 320, no. 19 (November 20, 2018): 2031–32. https://doi.org/10.1001/jama.2018.13073.
       Full Text  Link to Item
    • Patel, Yuval A., Jacqueline B. Henson, Julius M. Wilder, Jiayin Zheng, Schein-Chung Chow, Carl L. Berg, Stuart J. Knechtle, and Andrew J. Muir. “The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis.” Clin Transplant 32, no. 10 (October 2018): e13388. https://doi.org/10.1111/ctr.13388.
       Full Text  Link to Item
    • Proeschold-Bell, Rae Jean, Donna M. Evon, Christina Makarushka, John B. Wong, Santanu K. Datta, Jia Yao, Ashwin A. Patkar, et al. “The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial.” Contemp Clin Trials 72 (September 2018): 73–85. https://doi.org/10.1016/j.cct.2018.07.003.
       Full Text  Link to Item
    • Clement, Meredith E., Lauren F. Collins, Julius M. Wilder, Michael Mugavero, Taryn Barker, and Susanna Naggie. “Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.” Infect Dis Clin North Am 32, no. 2 (June 2018): 407–23. https://doi.org/10.1016/j.idc.2018.02.005.
       Full Text  Link to Item
    • Wilder, Julius M., and Andrew Muir. “Direct acting antivirals for the treatment of hepatitis C in ethnic minority populations.” Expert Opin Pharmacother 19, no. 5 (April 2018): 451–56. https://doi.org/10.1080/14656566.2018.1446945.
       Full Text  Link to Item
    • Collins, Lauren F., Austin Chan, Jiayin Zheng, Shein-Chung Chow, Julius M. Wilder, Andrew J. Muir, and Susanna Naggie. “Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection.” Open Forum Infect Dis 5, no. 1 (January 2018): ofx264. https://doi.org/10.1093/ofid/ofx264.
       Full Text  Open Access Copy  Link to Item
    • Henson, Jacqueline B., Yuval A. Patel, Julius M. Wilder, Jiayin Zheng, Shein-Chung Chow, Lindsay Y. King, and Andrew J. Muir. “Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.” Dig Dis Sci 62, no. 11 (November 2017): 3200–3209. https://doi.org/10.1007/s10620-017-4559-1.
       Full Text  Link to Item
    • Barrett, N. J., T. Vann, J. Wilder, K. ingraham, V. Worthy, X. Boyce, R. Reyes, et al. “Implementing a Health Equity Agenda at the Duke Cancer Institute.” Oncology Issues September-October 2016 (September 1, 2016): 48–57.
       Open Access Copy
    • Wilder, Julius M., Omobonike O. Oloruntoba, Andrew J. Muir, and Cynthia A. Moylan. “Role of patient factors, preferences, and distrust in health care and access to liver transplantation and organ donation.” Liver Transpl 22, no. 7 (July 2016): 895–905. https://doi.org/10.1002/lt.24452.
       Full Text  Open Access Copy  Link to Item
    • Wilder, Julius M., Lennox J. Jeffers, Natarajan Ravendhran, Mitchell L. Shiffman, John Poulos, Mark S. Sulkowski, Norman Gitlin, et al. “Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.” Hepatology 63, no. 2 (February 2016): 437–44. https://doi.org/10.1002/hep.28334.
       Full Text  Open Access Copy  Link to Item
    • Wilder, Julius, Anirudh Saraswathula, Vic Hasselblad, and Andrew Muir. “A Systematic Review of Race and Ethnicity in Hepatitis C Clinical Trial Enrollment.” J Natl Med Assoc 108, no. 1 (February 2016): 24–29. https://doi.org/10.1016/j.jnma.2015.12.004.
       Full Text  Open Access Copy  Link to Item
    • Wilder, Julius M., and Joanne A. P. Wilson. “Racial and Ethnic Disparities in Colon Cancer Screening in North Carolina.” N C Med J 77, no. 3 (2016): 185–86. https://doi.org/10.18043/ncm.77.3.185.
       Full Text  Open Access Copy  Link to Item
    • Wilder, Julius M., and Andrew J. Muir. “Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomes.” Ther Adv Chronic Dis 6, no. 6 (November 2015): 314–27. https://doi.org/10.1177/2040622315603642.
       Full Text  Open Access Copy  Link to Item
    • Patel, Keyur, and Julius Wilder. “Fibroscan.” Clin Liver Dis (Hoboken) 4, no. 5 (November 2014): 97–101. https://doi.org/10.1002/cld.407.
       Full Text  Link to Item
    • Wilder, Julius, and Keyur Patel. “The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease.” Med Devices (Auckl) 7 (2014): 107–14. https://doi.org/10.2147/MDER.S46943.
       Full Text  Open Access Copy  Link to Item

  • Conference Papers

    • Henson, J. B., D. Mohottige, J. M. Wilder, A. J. Muir, and L. M. McElroy. “Social Determinants of Health Impact Successful Listing for Liver and Kidney Transplant.” In American Journal of Transplantation, 22:363–64, 2022.
       Link to Item
    • Wong, Florence, Hugo E. Vargas, K Rajender Reddy, Mangesh R. Pagadala, Don C. Rockey, Angela Cheung, Deepika Devuni, et al. “AN AUTOMATIC LOW FLOW ASCITES PUMP IMPROVES ASCITES CONTROL AND QUALITY OF LIFE IN PATIENTS WITH CIRRHOSIS AND RECURRENT ASCITES.” In Hepatology, 76:S1155–56, 2022.
       Link to Item
    • Morris, Kostantinos, Alice Parish, Donna Niedzwiecki, Elizabeth Goacher, Julius Wilder, and Andrew J. Muir. “Financial Toxicity and Its Prevalence in Cirrhosis.” In American Journal of Gastroenterology, 116:S542–S542, 2021.
       Link to Item
    • Reichstein, Jonathan, Alice Parish, Stephanie Garbarino, Julius Wilder, Meira Epplein, Deborah A. Fisher, Donna Niedzwiecki, Andrew J. Muir, and David A. Leiman. “Variations and Racial Disparities in Helicobacter pylori Guideline Adherence for Eradication Testing.” In American Journal of Gastroenterology, 115:S670–71, 2020.
       Link to Item
    • Reichstein, Jonathan, Alice Parish, Stephanie Garbarino, Julius Wilder, Meira Epplein, Deborah A. Fisher, Donna Niedzwiecki, Andrew J. Muir, and David A. Leiman. “Antibiotic Resistance Rates in Helicobacter pylori Infection Derived from Retrospective Cure Rates.” In American Journal of Gastroenterology, 115:S670–S670, 2020.
       Link to Item
    • Samoylova, Mariya, Kara Wegermann, Brian Shaw, and Julius Wilder. “VARIABILITY IN CONSENT FOR HCV NAT plus ORGANS ON THE LIVER TRANSPLANT WAITING LIST.” In Hepatology, 72:857A-858A, 2020.
       Link to Item
    • Wegermann, Kara, Julius Wilder, Alice Parish, Donna Niedzwiecki, Ziad F. Gellad, Andrew Joseph Muir, and Yuval Patel. “BLACK, OLDER, UNMARRIED, AND MEDICAID PATIENTS WERE LESS LIKELY TO COMPLETE HEPATOLOGY VIDEO VISITS DURING COVID-19.” In Hepatology, 72:382A-383A, 2020.
       Link to Item
    • Helzberg, James H., Alice Parish, Donna Niedzwiecki, Charles Y. Kim, Julius M. Wilder, and Andrew J. Muir. “TIPS Outcomes According to Race and Ethnicity.” In American Journal of Gastroenterology, 113:S496–S496. NATURE PUBLISHING GROUP, 2018.
       Link to Item
    • Muir, Andrew Joseph, Jia Yao, Julius Wilder, Christina Makarushka, Kelly Keefe, James Henry Helzberg, Paolo Mannelli, et al. “The Alcohol Use Disorders Identification Test Screening in Patients with Hepatitis C.” In Hepatology, 68:908A-908A. WILEY, 2018.
       Link to Item
    • Spann, Ashley, Shakirat Salvador, Talisha Ramchal, Diana Mosquera, Joshua P. Lee, Lauren Donnangelo, Aaron Hein, Omar Martinez-Uribe, and Julius Wilder. “Prognostic Utility of Ammonia Testing on Admission in Cirrhotic Patients with and without Acute on Chronic Liver Failure (ACLF).” In Hepatology, 68:1344A-1345A. WILEY, 2018.
       Link to Item
    • Patel, Yuval, Jacqueline Henson, Julius Wilder, Matthew R. Kappus, Andrew S. Barbas, Cynthia A. Moylan, Donna Niedzwiecki, Andrew Joseph Muir, and Carl L. Berg. “The Impact of Advanced Age on Waiting List and Post-Transplantation Outcomes for NAFLD Patients.” In Hepatology, 68:683A-683A. WILEY, 2018.
       Link to Item
    • Wilder, Julius M., Jia Yao, Makarushka Christina, Donna Evon, Michael W. Fried, Susanna Naggie, Andrew J. Muir, and Rae Jean Proeschold-Bell. “ASSOCIATIONS OF ALCOHOL CONSUMPTION MOTIVES WITH DEPRESSION AND PAIN AMONG INDIVIDUALS WITH HEPATITIS C.” In Gastroenterology, 154:S1121–22. W B SAUNDERS CO-ELSEVIER INC, 2018.
       Link to Item
    • Dola, Tvisha, Brenna Hughes, Carla W. Brady, Julius M. Wilder, and Andrew J. Muir. “HEPATITIS C INFECTION KNOWLEDGE AND AWARENESS AMONG WOMEN OF CHILDBEARING AGE.” In Gastroenterology, 154:S1204–S1204, 2018.
       Link to Item
    • Henson, Jacqueline B., Julius M. Wilder, Yuval A. Patel, Jiayin Zheng, Shein-Chung Chow, Lindsay Y. King, and Andrew J. Muir. “Phenotypic Differences in Primary Sclerosing Cholangitis by Age Group.” In Hepatology, 64:185A-185A. WILEY, 2016.
       Link to Item
    • Patel, Yuval A., Jacqueline B. Henson, Julius M. Wilder, Jiayin Zheng, Shein-Chung Chow, Carl L. Berg, and Andrew J. Muir. “The Impact of HLA Serotyping and HLA Matching for PSC, PSC/AIH, AIH, PBC/AIH, and PBC Patients on Post-Liver Transplant Graft Failure: an Analysis of the UNOS Database.” In Hepatology, 64:500A-500A. WILEY, 2016.
       Link to Item
    • Wilder, Julius, Jackie Henson, Yuval Patel, Jiayin Zheng, Shein-Chung Chow, and Andrew Muir. “Racial Differences in Phenotype and Outcome Among Patients with Primary Sclerosing Cholangitis Listed for Liver Transplant: 2016 ACG Fellows-In-Training Award (Liver Category).” In American Journal of Gastroenterology, 111:S341–42. Ovid Technologies (Wolters Kluwer Health), 2016. https://doi.org/10.14309/00000434-201610001-00758.
       Full Text
    • Matta, Bassem, Julius M. Wilder, Tzu-Hao Lee, and Keyur Patel. “Predictive value of APRI and FIB4 scores for liver fibrosis assessment in comparison to Transient Elastography in chronic hepatitis C patients.” In Hepatology, 62:1129A-1130A. WILEY-BLACKWELL, 2015.
       Link to Item
    • Matta, Bassem, Julius Wilder, Tzu-Hao Lee, and Keyur Patel. “Predictive Performance of FIB 4 and APRI for Liver Fibrosis Assessment in Hepatitis C in Comparison to Transient Elastography.” In American Journal of Gastroenterology, 110:S885–S885. Ovid Technologies (Wolters Kluwer Health), 2015. https://doi.org/10.14309/00000434-201510001-02118.
       Full Text
    • Jeffers, Lennox J., Julius M. Wilder, Andrew J. Muir, Charles Howell, Yanni Zhu, Star Seyedkazemi, Jenny C. Yang, Phillip S. Pang, John G. McHutchison, and K Rajender Reddy. “Safety and Efficacy of Ledipasvir/Sofosbuvir Single-Tablet-Regimen in African Americans with Genotype 1 Chronic Hepatitis C Virus: A Retrospective Analysis of Phase 3 Studies.” In Hepatology, 60:319A-320A. WILEY-BLACKWELL, 2014.
       Link to Item
    • Oloruntoba, Omobonike O., Julius M. Wilder, Alastair D. Smith, Andrew J. Muir, and Cynthia A. Moylan. “The Influence of Race on Patient Preferences and Access to Orthotopic Liver Transplantation and Organ Donation.” In Hepatology, 60:963A-963A. WILEY-BLACKWELL, 2014.
       Link to Item
    • Saraswathula, Anirudh, Julius M. Wilder, and Andrew J. Muir. “A Systematic Review of Racial and Ethnic Diversity of Hepatitis C Virus Clinical Trials.” In Hepatology, 56:1087A-1087A. WILEY-BLACKWELL, 2012.
       Link to Item
• 

  Artistic Works & Non-Print Media

  • Video Recordings

    • The clinical utility of Fibroscan. Creator. 2014
    • Minority Perspectives in Healthcare. Editor. 2004

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.